BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 17978512)

  • 1. Development and optimization of intravenous puerarin emulsions formation by a novel complex-phase inversion-homogenization technology.
    Yue PF; Yuan HL; Li XY; Yang M; Zhu WF; Xiao XH
    Chem Pharm Bull (Tokyo); 2007 Nov; 55(11):1563-8. PubMed ID: 17978512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation optimization of self-emulsifying preparations of puerarin through self-emulsifying performances evaluation in vitro and pharmacokinetic studies in vivo.
    Quan DQ; Xu GX
    Yao Xue Xue Bao; 2007 Aug; 42(8):886-91. PubMed ID: 17944241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation, characterization, and pharmacokinetic evaluation of puerarin submicron emulsion.
    Yue PF; Yuan HL; Yang M; You RH; Cong LB; Zhu J; Wang Q; Zhu WF; Xiao XH
    PDA J Pharm Sci Technol; 2008; 62(1):32-45. PubMed ID: 18402366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Preparation and characterization of the puerarin submicron emulsion].
    Yue PF; Yuan HL; Yang M; You RH; Zhu WF; Xiao XH
    Yao Xue Xue Bao; 2007 Jun; 42(6):649-55. PubMed ID: 17702404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation development and pharmacokinetics of puerarin self-emulsifying drug delivery systems.
    Dong-Qin Q; Gui-Xia X; Xiang-Gen W
    PDA J Pharm Sci Technol; 2007; 61(1):37-43. PubMed ID: 17390702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The study to reduce the hemolysis side effect of puerarin by a submicron emulsion delivery system.
    Yue PF; Hai-Long Yuan HL; Zhu WF; Cong LB; Xie H; Liu ZG; Wang LJ; Xiao XH
    Biol Pharm Bull; 2008 Jan; 31(1):45-50. PubMed ID: 18175940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced oral bioavailability of puerarin using microemulsion vehicle.
    Wu H; Lu C; Zhou A; Min Z; Zhang Y
    Drug Dev Ind Pharm; 2009 Feb; 35(2):138-44. PubMed ID: 19040180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization and evaluation of self-microemulsifying sustained-release pellet formulation of puerarin for oral delivery.
    Zhang Y; Wang R; Wu J; Shen Q
    Int J Pharm; 2012 May; 427(2):337-44. PubMed ID: 22366381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative physicochemical characterization of phospholipids complex of puerarin formulated by conventional and supercritical methods.
    Li Y; Yang DJ; Chen SL; Chen SB; Chan AS
    Pharm Res; 2008 Mar; 25(3):563-77. PubMed ID: 17828444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Preparation of puerarin liposome and its oral absorption in rat].
    Gu YZ; Zhou W; Zhai GX
    Zhong Yao Cai; 2007 Aug; 30(8):970-3. PubMed ID: 18074848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacokinetics and bioavailability of Puerarin self-microemulsion in Beagle dogs].
    Chen XX; Yuan S; Li G; Liang YY; Zhou X; Xie CS; Long CF
    Zhong Yao Cai; 2011 May; 34(5):750-3. PubMed ID: 21954564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of drug-oil properties on fabrication of drug nanocrystalline self-stabilizied Pickering emulsions].
    Wang F; Wang S; Yi T; Zhang JF
    Zhongguo Zhong Yao Za Zhi; 2017 Oct; 42(19):3739-3746. PubMed ID: 29235289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on preparation and absolute bioavailability of a self-emulsifying system containing puerarin.
    Quan DQ; Xu GX; Wu XG
    Chem Pharm Bull (Tokyo); 2007 May; 55(5):800-3. PubMed ID: 17473473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Improvement of solubility of puerarin through deoxycholate/phospholipid mixed micelle preparing technology].
    He D; Han L; Wang Y; Ni J; Du S
    Zhongguo Zhong Yao Za Zhi; 2010 Jun; 35(11):1395-8. PubMed ID: 20822006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A microemulsion of puerarin-phospholipid complex for improving bioavailability: preparation, in vitro and in vivo evaluations.
    Wu JY; Li YJ; Han M; Hu XB; Yang L; Wang JM; Xiang DX
    Drug Dev Ind Pharm; 2018 Aug; 44(8):1336-1341. PubMed ID: 29513046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulation and pharmacokinetics evaluation of puerarin nanocrystals for intravenous delivery.
    Wang Y; Ma Y; Ma Y; Du Y; Liu Z; Zhang D; Zhang Q
    J Nanosci Nanotechnol; 2012 Aug; 12(8):6176-84. PubMed ID: 22962724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation optimization and bioavailability after oral and nasal administration in rabbits of puerarin-loaded microemulsion.
    Yu A; Wang H; Wang J; Cao F; Gao Y; Cui J; Zhai G
    J Pharm Sci; 2011 Mar; 100(3):933-41. PubMed ID: 20862776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Stability optimization of puerarin nanocrystalline self-stabilizied Pickering emulsion by response surface methodology].
    Zhang JF; Zhang J; Wang F; Wang S; Wang M; Yi T
    Zhongguo Zhong Yao Za Zhi; 2017 Aug; 42(15):2969-2976. PubMed ID: 29139265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The study on the entrapment efficiency and in vitro release of puerarin submicron emulsion.
    Yue PF; Lu XY; Zhang ZZ; Yuan HL; Zhu WF; Zheng Q; Yang M
    AAPS PharmSciTech; 2009; 10(2):376-83. PubMed ID: 19381837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Preparation of puerarin solid self-microemulsion].
    Yu AH; Zhai GX; Cui J; Liu H
    Zhong Yao Cai; 2006 Aug; 29(8):834-8. PubMed ID: 17076244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.